Gutgesell RM, Nogueiras R, Tschp MH, Mller TD
NF-kappaB Pathway Inhibition Targeted Anti-Inflammatory Control KPV provides potent anti-inflammatory effects through direct inhibition of nuclear factor-kappa B (NF-kappaB), distinguishing KLOW from GLOW through enhanced inflammation control[3]: Competitive blocking of importin-alpha3 interaction with NF-kappaB p65/RelA subunit Prevention of NF-kappaB nuclear translocation in activated cells Inhibition of pro-inflammatory gene transcription Reduction of cytokine production including TNF-alpha, IL-1beta, and IL-6 PepT1-mediated cellular uptake enabling intracellular anti-inflammatory action This mechanism operates at nanomolar concentrations and works through a melanocortin receptor-independent pathway, providing inflammation control without hormonal side effects while complementing the other components regenerative actions
Apply a small amount of the product to a discreet area of skin and wait 24 hours to see if any adverse reactions occur
Data from post-marketing surveillance studies remains sparse
Colonial Medical Supply, Franconia, NH, USA) at 5, 8, and 12 W as we previously described 11,14,49,53